Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 358 M361 M353 M354 M369 M397 M 1.47 B Research & development —————— — Operating income 286 M412 M303 M247 M316 M470 M 1.34 B Non-Operating Income, Total -32 M-33 M-27 M-22 M-25 M30 M -44 M Interest expense, net of interest capitalized 26 M26 M25 M24 M26 M28 M 103 M Non-Operating Income, excl. Interest Expenses -25 M-26 M-25 M-26 M-26 M0 -77 M Unusual income/expense -7 M-7 M-2 M4 M1 M2 M 5 M Pretax income 254 M378 M276 M227 M291 M440 M 1.23 B Equity in earnings —————— — Taxes 56 M95 M76 M50 M63 M107 M 296 M Non-controlling/minority interest 12 M13 M11 M12 M15 M15 M 53 M After tax other income/expense —————— — Net income before discontinued operations 186 M270 M189 M165 M213 M318 M 885 M Discontinued operations —————— — Net income 186 M270 M189 M165 M213 M318 M 885 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 186 M270 M189 M165 M213 M317 M 884 M Basic earnings per share (Basic EPS) 0.871.290.910.81.051.6 4.36 Diluted earnings per share (Diluted EPS) 0.871.280.90.811.051.6 4.36 Average basic shares outstanding 212 M210 M209 M209 M204 M201 M — Diluted shares outstanding 213 M211 M209 M210 M204 M201 M — EBITDA 321 M448 M341 M266 M355 M509 M 1.47 B EBIT 286 M412 M303 M227 M317 M471 M 1.32 B Cost of revenue 1.16 B1.28 B1.26 B1.19 B1.23 B1.12 B 4.8 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 35 M36 M38 M39 M38 M38 M 153 M